We will conduct a Tau PET scan in cognitively normal older adults, enrolled in the Aging Brain Cohort Dedicated to Diversity Study (ABCD2-Tau) study at the University of Pennsylvania's Penn Memory Center/Alzheimer's Disease Core Center (PMC/ADC).Study duration will generally be a one-day study visit for PET imaging, but all subjects will be followed annually as part of their participation in the ABCD2 study. Findings from this study will likely provide insight into the mechanisms and distinctions of age-related cognitive decline and that of preclinical Alzheimer's Disease.
Study Type
OBSERVATIONAL
Enrollment
111
\[18F\]AV-1451 has been developed as a positron emitting radiopharmaceutical for in vivo imaging of tau protein aggregates.
Hospital of the University of Pennsylvania - Penn Memory Center
Philadelphia, Pennsylvania, United States
Uptake of [18F]AV-1451 in the medial temporal lobe
A quantitative measurement of \[18F\]AV-1451(standardized value uptake ratio - SUVR) within the medial temporal lobe (MTL).from PET/CT
Time frame: 4 years
Volume of medial temporal lobe subregion
A quantitative measurement of volume (milimeters - mm) of medial temporal lobe (MTL) subregion from a high resolution MRI.
Time frame: 4 years
Thickness of medial temporal lobe subregion
A quantitative measurement of thickness (milimeters - mm) of medial temporal lobe (MTL) subregion from a high resolution MRI.
Time frame: 4 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.